Investigational Drug 1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Investigational Drug 1, covering 2012-03-19 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) [Phase 3]